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ABSTRACT: Sprouty (Spry) proteins are negative
feedback inhibitors of receptor tyrosine kinase signaling.
Downregulation of Spry2 has been demonstrated to pro-
mote elongative axon growth of cultured peripheral and
central neurons. Here, we analyzed Spry2 global knock-
out mice with respect to axon outgrowth in vitro and
peripheral axon regeneration in vivo. Neurons dissociated
from adult Spry2 deficient sensory ganglia revealed stron-
ger extracellular signal-regulated kinase activation and
enhanced axon outgrowth. Prominent axon elongation
was observed in heterozygous Spry21/2 neuron cultures,
whereas homozygous Spry22/2 neurons predominantly
exhibited a branching phenotype. Following sciatic nerve
crush, Spry21/2 mice recovered faster in motor but not
sensory testing paradigms (Spry22/2 mice did not tolerate
anesthesia required for nerve surgery). We attribute the
improvement in the rotarod test to higher numbers of
myelinated fibers in the regenerating sciatic nerve, higher
densities of motor endplates in hind limb muscles and
increased levels of GAP-43 mRNA, a downstream target
of extracellular regulated kinase signaling. Conversely,
homozygous Spry22/2 mice revealed enhanced mechano-
sensory function (von Frey’s test) that was accompanied
by an increased innervation of the epidermis, elevated
numbers of nonmyelinated axons and more IB4-positive
neurons in dorsal root ganglia. The present results cor-
roborate the functional significance of receptor tyrosine
kinase signaling inhibitors for axon outgrowth during
development and nerve regeneration and propose Spry2
as a novel potential target for pharmacological inhibition
to accelerate long-distance axon regeneration in injured
peripheral nerves. VC 2014 Wiley Periodicals, Inc. Develop Neurobiol
75: 217–231, 2015
Keywords: innervation; sensory; motor; ganglion; axot-
omy; fibroblast growth factor; nerve growth factor
INTRODUCTION
In contrast to the central nervous system, peripheral
axons regenerate after injury mainly because of the
more permissive environment. Yet, peripheral nerve
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lesions often cause persistent functional deficits that
are at least partially due to extensive branching of
regenerating axons at the lesion site (Gordon, 2009).
Therefore, improvement of elongative axon growth is
required for faster long-distance regeneration of
axons to the skin and into target muscles, which atro-
phy in the absence of reinnervation.
Following injury to peripheral nerves approximately
half of the affected neuron population sends out axons
that enter glial guidance channels in response to
secreted neurotrophins and other neuronal growth fac-
tors (Klimaschewski et al., 2013). These lesion-
associated polypeptides create an environment that is
highly supportive for axon regrowth and ensure that
the majority of regenerating axons are directed toward
the distal nerve stump. Unfortunately, however, most
neurotrophic factors act as strong stimulators of axonal
sprouting at the lesion site. Although some of the axon
branches will withdraw at later stages, the sprouting
effect contributes to the misdirection of reinnervation
that results in lack of functional recovery observed in
many patients with nerve injuries.
By activation of neuronal receptor tyrosine kinases,
neurotrophic factors stimulate several signaling path-
ways that are involved in both, axon elongation and
branching. However, the downstream molecular mech-
anisms affecting the axonal cytoskeleton are clearly
different (Gallo, 2011). Sprouty (Spry) proteins belong
to a group of negative feedback inhibitors of receptor
tyrosine kinase signaling comprising four members
(Mason et al., 2006). They are implicated in cellular
proliferation and differentiation such as angiogenesis
(Impagnatiello et al., 2001), branching morphogenesis
(Tang et al., 2011) and brain development (Yu et al.,
2011). Sprys function as growth factor antagonists,
thereby fine-tuning receptor tyrosine kinase activities
mainly by specific interference with processes
upstream of extracellular signal-regulated kinase
(ERK), although their precise biochemical mecha-
nisms remain controversial (Mason, 2007).
In PC12 pheochromocytoma cells, overexpression
of Spry1/2 blocks neurite outgrowth by nerve growth
factor (NGF) or fibroblast growth factor (FGF-2;
Gross et al., 2001). In contrast, nonphosphorylated
dominant-negative Spry1/2 (Hanafusa et al., 2002) or
Spry4 (Sasaki et al., 2001) potentiate FGF-2 induced
neurite outgrowth. In the peripheral nervous system,
downregulation of Spry2 induces axon outgrowth
through enhanced Ras/Raf/ERK-signaling, whereas
overexpression inhibits axon growth without affect-
ing cell viability (Hausott et al., 2009).
The expression of Sprys is regulated by growth
factors. In dorsal root ganglion (DRG) cultures,
Spry1 is upregulated by FGF-2 and NGF, whereas
Spry4 is induced by FGF-2 only (Hausott et al.,
2009). In response to a peripheral nerve lesion, how-
ever, Spry mRNA levels do not change. Nevertheless,
Spry2 is regulated post-transcriptionally, with Spry2
protein levels being reduced as a result of an induc-
tion of microRNA-21 (miR-21) following nerve
injury in vivo (Strickland et al., 2011).
In this study, we set out to investigate axon out-
growth and nerve regeneration in Spry2 mutant mice
as compared to wildtype (wt) mice in vitro and in
vivo. The sciatic nerve, skin, and muscle innervation
as well as functional recovery in response to nerve
crush injury was assessed as an indicator for a possi-
ble inhibitory role of Spry2 during nerve develop-
ment and peripheral nerve regeneration.
MATERIALS AND METHODS
Mutant Animals
Spry2-delta-ORF (Spry2tm1.1Mrt/Mmnc) knockout mice
were obtained from MMRRC (Mutant Mouse Regional
Resource Centre, University of North Carolina at Chapel
Hill) on a mixed genetic background. Backcrossing was
performed on a 129 S1/SVImJ background until the tenth
generation. By the time of weaning most Spry22/2 mice
had died, and the remaining homozygous mice were
smaller than normal as reported previously (Taketomi
et al., 2005). As a result of their reduced weight, only few
homozygous mice reached adult age, but they were not able
to survive anesthesia required for nerve surgery. Therefore,
lesion experiments were performed in Spry21/2 mice only.
Primary Neuron Cultures
Lumbar DRG were harvested from 8–10 weeks old mice as
previously published (Andratsch et al., 2009). Following
removal of connective tissue, ganglia were incubated in lib-
erase blendzyme 1 (Roche, 9 mg/100 mL DMEM) for 60
min. After rinsing with phosphate-buffered saline (PBS), 13
trypsin-EDTA (Invitrogen) was added for 15 min, and DRG
were washed with TNB 100TM medium (Biochrom) supple-
mented with L-glutamin (Invitrogen), penicillin G sodium,
streptomycin-sulfate (Invitrogen), and protein-lipid-
complexTM (Biochrom). Ganglia were dissociated with a
fire-polished Pasteur pipette and centrifuged at low speed
(10 min, 500 rpm) through a 3.5% bovine serum albumin
(BSA) gradient (Sigma Aldrich) to minimize the number of
non-neuronal cells. Neurons were resuspended, plated at a
density of 50–80 per glass coverslip coated with poly-L-
lysine/laminin (Sigma Aldrich) and cultivated in TNB
medium at 37C in 5% CO2 for 24 h in the presence of
FGF-2 (Sigma) or mNGF 2.5S (Alomone Labs) if required.
Superior cervical ganglion (SCG) neurons were obtained at
postnatal day 5–7, dissociated, plated on a poly-L-ornithine/
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laminin substrate and treated with 5 ng/mL NGF to maintain
survival for 24 h as described before (Loy et al., 2011).
Immunocytochemistry and
Histochemistry
After 24 h in culture, neurons were fixed with 4% paraformal-
dehyde (PFA) for 20 min, permeabilized with 0.01% Triton
X-100 (Sigma Aldrich) in PBS for 5 min and blocked with
blocking buffer (20% goat serum in PBS) for 30 min. Cells
were incubated with primary antibodies against neuron-
specific b-III Tubulin (TuJ1, R&D systems, 1:1000), pERK
(Cell Signaling, 1:250), ERK (Cell Signaling, 1:250), Spry2
(Upstate, 1:200), CGRP (AbD SEROTEC, 1:200), S100
(Abcam, 1:200), GAP-43 (Millipore, 1:500), PGP 9.5 (gift
from Anne Zurn, Lausanne, Switzerland, 1:2000), or with lec-
tine IB4 (Invitrogen, 1:1000), all diluted in blocking buffer
for 1 h at room temperature (RT), washed with PBS and incu-
bated with secondary antibodies (Alexa-488 goat anti-rabbit,
Alexa-594 chicken anti-mouse, Invitrogen, 1:1000) for 30
min at RT. Nuclei were stained with DAPI (1:1000 in PBS)
and coverslips embedded in Moviol (Calbiochem).
For histology of sciatic nerves and sensory ganglia, tissues
were fixed in 4% PFA overnight. Following three washes in
PBS, specimens were incubated in 15% sucrose overnight,
transferred to 100% OCT compound (TissueTek) and rapidly
frozen in liquid nitrogen. For neuron counting, cryosections
from the right lumbar DRG (L3–L5) and corresponding spinal
cord segments of 8–10 weeks old mice were stained with cre-
syl violet. Nissl-positive neuronal profiles with nucleus were
counted in every fifth section and numbers corrected accord-
ing to Abercrombie’s formula taking into account the section
thickness and mean nuclear diameter (Abercrombie, 1943).
For immunolabeling, DRG and sciatic nerve cryosec-
tions (10 and 20 lm, respectively) were permeabilized with
0.3% Triton X-100 (Sigma Aldrich) and blocked with 5%
BSA and 15% goat serum in PBS for 4 h at RT. Samples
were then incubated with primary antibodies (same as
above) overnight at 4C followed by 1 h at RT, rinsed three
times for 10 min in PBS and incubated with secondary anti-
bodies (same as above) for 2 h at RT, rinsed and embedded
with fluorescent mounting medium (Dako).
Following double-labeling immunofluorescence against
GAP-43 and S100 on 20 lm cryosections of the sciatic
nerve randomly chosen regions of interest (3570 lm2) were
measured and the mean intensity values determined after
background subtraction. Confocal microscopy was per-
formed with a Leica TCS SP5 microscope. Images were
acquired with a 633 glycerol objective (N.A. 1.3) and
imaging parameters for excitation and detection kept the
same for all conditions (laser intensities: 405 diode - 15%,
argon 488 - 12%, DPSS 561 - 10%).
For analysis of muscle innervation, the gastrocnemius
muscle was dissected from perfusion fixed mice (4% PFA)
at 7, 14, and 28 days after sciatic nerve crush, cryoprotected
with 25% sucrose overnight, and frozen in OCT compound.
Cryosections (50 lm) were stained with Alexa-Fluor-488-
conjugated-a-bungarotoxin (Molecular Probes, 1:3000).
Images were acquired with a 53 objective and the density
of motor endplates determined (as number per area).
For analysis of epidermal sensory innervation, the gla-
brous hind paw skin was fixed for 1 h in 4% PFA, cryopro-
tected in 20% sucrose at 4C for at least 24 h, embedded
and frozen in optical cutting medium (OCT). Cryostat sec-
tions of 20 lm were processed for immunofluorescence as
described above. Analysis of immunostaining was per-
formed blinded to genotype. Images were processed using
EMBL ImageJ (V1.45h, NIH) or Corel Photopaint X3 soft-
ware. Quantification of epidermal sensory innervation den-
sity was performed as described before (Baumer et al.,
2014). In brief, labeled nerve fibers in the epidermis of at
least 10 randomly chosen confocal micrographs (20 lm
stacks) of four animals per genotype were counted and the
fiber density (# of fibers/1000 lm2) was calculated. Epider-
mal thickness was determined in at least 10 randomly cho-
sen confocal micrographs of four animals per genotype
with the Leica Application Suite (LAS lite, version 2.6.0)
and the fiber length was calculated by multiplying the epi-
dermal thickness with the fiber density.
Fluorescently labeled cultured neurons and tissue sections
were analyzed using confocal or conventional fluorescence
microscopy (for pERK/ERK intensity measurements and
axon morphometry). The longest vector from the center of the
cell body to one of the growth cones (maximal distance), the
number of all axonal branch points per neuron, and the total
axonal length were determined for each neuron applying
Metamorph (Visitron) and WIS-Neuromath software (Rishal
et al., 2013). All morphologically intact neurons per dish with
axons longer than two cell body diameters were analyzed (Kli-
maschewski et al., 2002). Evaluation of the average fluores-
cence intensity was performed after background subtraction
(Bavassano et al., 2013) and images processed using Meta-
morph, Fiji bundle for ImageJ, and Adobe Illustrator CS5.
Quantitative RT-PCR
Under deep anesthesia, mice were sacrificed at days 1, 3,
and 14 post injury and 7 mm of the sciatic nerve distal to
the lesion were dissected. The corresponding portion of the
right sciatic nerve served as internal control. For determina-
tion of Spry mRNAs in DRG na€ıve mice were used. All
samples were immediately frozen in liquid nitrogen. The
RNA was extracted using TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. Total RNA of
0.5 lg was subjected to a reverse transcriptase reaction in
25 lL reaction volume containing 13 buffer, 0.1 lg/lL
BSA, 0.05% Triton X-100, 1 mM dNTPs, 7.5 lM random
hexanucleotide primers, 40 U RIBOlock, and 200 U Rever-
tAidTM M-MuLV reverse transcriptase (all by Fermentas).
The reaction was performed for 10 min at 25C, 90 min at
42C, and 10 min at 90C. Quantitative real-time PCR for
GAP-43, b-actin, Sprouties, and the housekeeping gene
TATA box binding protein (TBP) was performed using an
ABI Prism 7300 (Applied Biosystems) detection system
applying SYBR Green chemistry or fluorescent TaqMan
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technology. cDNA was diluted 10 times before analysis
and 5 lL were analyzed in a total volume of 20 lL. For
each cDNA sample, three technical replicates were aver-
aged. The reactions were carried out in 40 cycles (primer
annealing temperature: 60C). For b-actin and TBP, the
reaction was performed in 13 PowerGREEN Master Mix
(Applied Biosystems) and 300 nM forward and reverse
primer. Dissociation curves were routinely performed to
check for the presence of a single peak corresponding to
the required amplicon. Normalized reporter fluorescence
(Rn) for each cycle was obtained by normalizing SYBRGreen
to the ROX signal. For GAP-43, the reaction was performed in
13 TaqManVR Universal PCR Master Mix and 13 TaqMan
Gene Expression Assay (Applied Biosystem). The data from
real-time PCR experiments were analyzed using the DDCt
method for relative quantification. Expression levels were nor-
malized to the TBP. As calibrator the contralateral sciatic nerve
was chosen. Primer sequences were: TBP forward 50-
GATCAAACCCAGAATTGTTCTCC-30, TBP reverse 50-
GGGGTAGATGTTTTCAAATGCTTC-30, b-actin forward
50-CTTCTTTGCAGCTCCTTCGTTGCC-30, b-actin reverse
50GACGACCAGCGCAGCGATATC-30, Spry1 forward 50-
CATGGCAGATTTCCGCTG-30, Spry1 reverse 50-CTGCT
ATTCACATTGGCTGGTATG-30, Spry2 forward 50-CACGG
AGTTCAGATGTGTTCTAAGC-30, Spry2 reverse 50-ATGT
TTGTGCTGAGTGGAGGGG-30, Spry3 forward 50-AGCA
ATGATTATGTGGAACGGC-30, Spry3 reverse 50-TTCTCC
CTTCAGAGCACCATCG-30, Spry4 forward 50-TCGGGT
TCGGGGATTTACAC-30, Spry4 reverse 50-GGCTGGTC
TTCATCTGGTCAATG-30.The primers for GAP-43 were
designed by Applied Biosystems (TaqMan Gene Signature
Mm00500404_m1).
Surgical Procedures and Behavioral
Experiments
All in vivo experiments were performed with the approval of
the ethical commission of the Austrian government
(BMWF-66.011/0086-II/10b/2010). The guidelines of the
EU concerning animal care were closely observed. Spry21/2
mice weighing approximately 30 g were used (8–12 weeks
of age). The cages were housed in a temperature and humid-
ity controlled room with 12/12 h light/dark cycles and ani-
mals fed with standard chow and water ad libitum.
Mice were anesthetized (6–8 mg/kg body weight of Xyla-
zin and 90–120 mg/kg body weight of Ketamine) followed by
exposure of the sciatic nerve at upper thigh level. The nerve
was crushed with a defined force of 1.9 N for 23 1 min using
a feedback controlled electronic squeezer (rodent pincher,
Bioseb) at two adjacent sites. Following wound closure and
recovery from surgery, the mice were behaviorally analyzed
by several testing protocols twice per week (always by the
same person). The paw withdrawal latency in response to an
increasing heat stimulus at the plantar side of the hindpaw
was measured (Hargreaves’ test). Mechanical sensitivity (von
Frey’s test) was tested after application of fine-gauge metal
wires of different forces. For testing mainly motor function,
the time was measured that an animal stays on an accelerating
rod (rotarod) as a measure of balance, coordination, and
motor-planning. One week before nerve surgery all of the ani-
mals were accustomed to the testing apparatus. Animals were
coded so that investigators conducting the behavioral and his-
tological assessments were blind to the treatment conditions.
Nerve Histology
Mice were euthanatized at day 28 postoperatively, and
5 mm of the sciatic nerve distal to the lesioned side
removed. The samples were fixed in 4% PFA and 2.5% glu-
taraldehyde, embedded in Glauerts’ resin and prepared for
quantitative analysis of myelinated nerve fibers (Raimondo
et al., 2009). Series of semithin transverse sections (2.5
lm) were cut using an Ultracut microtome (Leica Micro-
systems) and stained with toluidine blue. In each nerve,
design-based quantitative morphology was performed.
On one randomly selected toluidine-blue-stained semithin
section, the total cross-sectional area of the whole nerve was
measured using light microscopy. Applying a semiautomatic
morphometry program, (MetaMorph, Visitron) the total fiber
number, the circle-fitting diameter of the fiber, and the axon as
well as myelin thickness were determined. For analysis of
unmeylinated fibers, transmission electron microscopy was
performed. The number of unmyelinated fibers, myelinating
Schwann cells, and unmyelinating Schwann cells was quanti-
fied in defined areas (12.2 3 16.2 lm2) at 8000 fold magnifi-
cation selected by a systematic random sampling protocol. In
each sampling field, the edge effect was avoided using a two-
dimensional dissector procedure based on sampling the tops of
fibers or nuclei. The mean fiber density was calculated by
dividing the total number of fibers within the sampling field by
its area. The total number of fibers was estimated by multiply-
ing the mean fiber density with the total cross-sectional area of
the whole nerve section.
Statistical Analysis
Statistical analysis was performed using one-way ANOVA
followed by Tukey’s post hoc test or Mann-Whitney test if
appropriate. All data points are presented as mean val-
ues6 SD or SEM applying Prism or Sigma Stat software.
For testing rotarod data over time, a linear regression was fit-
ted. An exponential function was applied for describing the
learning curve of nonlesioned mice. Data from behavioral
tests were subjected to two-way repeated measures analysis
of variance with multicomparison post hoc tests. Differences
between groups were considered statistically significant if
p< 0.05 (*p< 0.05, **p< 0.01, or ***p< 0.001).
RESULTS
Peripheral Innervation in Spry2 Knockout
Mice
Homozygous Spry2 knockout mice 6–8 weeks of age
were smaller (appr. 50% reduction in body weight)
than their wildtype (wt) or heterozygous littermates
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[Fig. 1(A)]. The homozygous mice did not even sur-
vive mild anesthesia required for surgery. Therefore,
they were used for cell culture, behavioral testing,
and tissue extraction, but not for nerve lesion
experiments.
The threshold for responding to von Frey filaments
was reduced indicating higher mechanosensitivity in
homozygous Spry2 mice [Fig. 1(B)], whereas ther-
monociception was impaired [Fig. 1(C)]. The rotarod
treadmill test for motor coordination and balance did
not reveal statistically significant differences between
the three groups [Fig. 1(D)].
The behavioral differences in sensory tests were
accompanied by changes in skin innervation and in
axon numbers in the sciatic nerve. Comparison of the
distribution of nociceptive C-fiber terminals in the
glabrous skin of WT and Spry22/2 mice using the
pan-neuronal marker PGP9.5 revealed an increase in
the total length of nerve endings [NE; Fig. 2(A,B)].
This was due to a thickening of the epidermis which
may have been caused by enhanced proliferation of
keratinocytes in this global Spry2 knockout mouse
model (Mason et al., 2006). Quantitative measure-
ments of the total number of nerve endings in the epi-
dermis (per section area) revealed no difference
between genotypes (2.756 0.12 NE/1000 lm2 for wt
and 2.916 0.04 NE/1000 lm2 for Spry22/2 mice),
that is, the density was unchanged. However, a 1.5-
fold increase of free nerve ending length was
observed in Spry22/2 animals [Fig. 2(B); 88.36 3.5
Figure 1 Comparison of body weight of young adult Spry2 deficient mice and behavioral testing.
Spry22/2 mice are significantly smaller in comparison with wt or Spry21/2 mice (A; mean6 SEM
of n> 6 mice per group). Sensory tests reveal a lowered mechanical threshold in response to von
Frey hairs (B), but an increased thermal threshold as indicated by the paw withdrawal latency
(PWL) following a heat stimulus in homozygous Spry2 knockout mice (C). A statistically nonsigni-
ficant trend toward reduced motor coordination was observed on the rotarod treadmill (accelerating
mode) in Spry2 deficient mice (D). Mean6SEM of n> 6 mice per group.
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lm/1000 lm2 for wt and 1246 6.6 lm/1000 lm2 for
Spry22/2 mice; **p< 0.01].
Morphometric analysis of the sciatic nerve [Fig.
2(C–I)] did not reveal differences in number of
myelinated axons, in myelin thickness or in fiber
diameter of homozygous Spry2 knockout mice, but
uneven fiber calibre distributions were detected [Fig.
2(E)]. However, the number of nonmyelinated axons
was significantly increased in Spry22/2 mice follow-
ing quantification of Remak bundles in EM images
[containing small-diameter axons surrounded by
cytoplasmic processes of a nonmyelinating Schwann
cell; Fig. 2(I)]. Conversely, heterozygous Spry2
knockout mice exhibited significantly more
Figure 2 Labeling of axons in the epidermis using a pan-neuronal marker (PGP9.5) and Hoechst
stain to identify nuclei demonstrate an increased total length of nerve endings (per area) in the skin
of Spry22/2 mice which is due to an enhanced epidermal thickness (A,B). Histomorphological
analysis of the sciatic nerve demonstrates myelinated axons in LM images (C–E). More myelinated
axons are found in Spry21/2 nerves (F), but myelin thickness (G) and fiber diameters (H) are not
affected in either Spry2 genotype as compared to wt. Note the uneven distribution of small- and
large-sized myelinated axons in sciatic nerves of Spry22/2 nerves (E). While the number of
myelinated axons is unchanged (F), Remak bundles as a correlate for the number of nonmyelinated
axons are more frequently observed in Spry22/2 mice (I). Mean6SEM of n> 4 mice per group.
Bar5 40 lm (B) or 20 lm (C–E)
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myelinated axons in sciatic nerves while the number
of nonmyelinated axons was only slightly increased
[Fig. 2(F,I)].
With regard to muscle innervation the number of
motor endplates was nonsignificantly increased in
homozygous Spry2 mice (0.26 16% more endplates
in Spry21/2 and 10.86 4.4% more endplates in
Spry22/2 mice as compared to wt). However, the
endplate size was significantly smaller (2966 9.9
lm2 in Spry22/2, 4436 13 lm2 in Spry21/2 and
6926 19 lm2 in wt mice, mean6 SEM of n5 3
mice).
Schwann cells and satellite cells in the DRG were
devoid of Spry2 immunoreactivity in wt or knockout
nerves consistent with our previous observations in
the rat DRG (Hausott et al., 2009).
To detect a possible influence of Spry2 reduction
on neuron number during development, we analyzed
the lumbar DRG (L3, L4, L5) that project into the
mouse sciatic nerve. No difference between the geno-
types was detected in overall neuron number of the
L3–L5 DRG [Fig. 3(A)]. In addition, the total num-
ber of lumbar motoneurons in the spinal cord was
similar in Spry2 deficient mice as compared to wt
(data not shown). Immunohistochemical staining
revealed no difference in Spry2 protein levels in
small (<500 lm2) versus large-sized DRG neurons
(>500 lm2). The average Spry2 immunofluorescence
intensities (measured in arbitrary units after back-
ground correction with background defined as fluo-
rescence detected in Spry22/2 neurons) were
4716 28 in small sized and 4906 41 in large-sized
neurons (mean6 SEM, n> 30 per group).
However, the expression of markers for DRG sub-
populations changed in Spry22/2 mice with regard to
the peptidergic (calcitonin gene-related peptide,
CGRP) and nonpeptidergic (IB4) unmyelinated noci-
ceptive neurons, respectively [Fig. 3(B,C)]. While
the relative frequency of CGRP positive neurons
(mainly thermonociceptive) decreased, the proportion
of IB4 binding neurons (mainly mechanosensitive)
increased, which may underlie the differences
observed in the sensory tests [Fig. 1(B,C)].
Quantitative RT-PCR and Western blot analysis
confirmed that Spry2 mRNA and protein levels
decrease by 50–60% in DRG of heterozygous Spry2
mice, while no upregulation or downregulation of the
other Spry isoforms (Spry1, Spry3, or Spry4) was
observed (Supporting Information Fig. 1).
Axon Outgrowth of Spry2 Deficient
Neurons in vitro
The increase in epidermal innervation and in non-
myelinated axon numbers in Spry22/2 mice with no
elevation in total DRG neuron number suggested that
sensory axon branching is enhanced in Spry2 defi-
cient neurons. Therefore, we investigated axon out-
growth of DRG neurons obtained from young adult
homozygous and heterozygous Spry2 knockout mice.
Dissociated neurons were plated on a growth promot-
ing substrate (poly-L-lysine/laminin) and labeled with
anti-tubulin antibodies after 24 h in culture.
Obvious differences were apparent with regard to
the axon outgrowth patterns of sensory neurons
Figure 3 Overall DRG neuron number is not changed in Spry2 deficient mice (A; mean6 SEM of
n> 4 mice per group). However, CGRP immunoreactive and IB4 binding neurons are differentially
distributed in Spry22/2 DRG (B). The relative proportion of CGRP expressing neurons is smaller,
while IB4 binding neurons are more frequently observed. Note the reduced size of Spry2 deficient
neurons expressing CGRP or binding IB4 in double-labeled confocal images (C). Mean6 SEM of
n> 500 neurons with n> 3 mice per group. Bar5 50 lm.
Sprouty2 Inhibits Long-Distance Nerve Regeneration 223
Developmental Neurobiology
Figure 4 Representative examples of neuronal morphologies of young adult DRG neurons stained
for the tubulin marker Tuj-1. Inverted fluorescence images are shown to document the different com-
plexities of the axonal tree (A–C). In cultures obtained from Spry21/2 mice, the length of the longest
axon (maximal distance) is significantly increased (D). In contrast, axonal branching is particularly
enhanced in untreated Spry22/2 neurons (E). Following treatment with NGF (100 ng/mL), FGF-2
(100 ng/mL), or vehicle for 24 h the total axonal length (F) and axon elongation are promoted mainly
in heterozygous Spry2 knockout cultures. Labeling for nonmyelinating neurons reveals that axonal
elongation and branching is significantly enhanced in the CGRP positive neuronal subpopulation,
whereas IB4 binding neurons are less responsive in Spry2 deficient cultures (G–I). Compared to wt
(J) activated ERK levels are significantly increased in DRG neurons dissociated from Spry21/2 (K)
or Spry22/2 (L) mice that reveal the highest ratios (pERK/ERK) of fluorescence intensities following
background correction (M). Mean6 SEM of n 3 independent experiments with a total number of
neurons> 80 (D–F),> 40 (G–I) and,> 20 (M) per group. Bar5 100 lm
[Fig. 4(A–C)]. The length of the longest axon per neu-
ron as a measure for the neuronal capacity to induce
axon elongation, the total axon length, and the number
of axonal branch points were significantly enhanced in
both genotypes when compared to wt. However, heter-
ozygous and homozygous Spry2 knockout neurons
differed with regard to their axon outgrowth pattern:
Spry21/2 neurons exhibited a tendency toward axon
elongation [Fig. 4(B,D)], while homozygous neurons
revealed an axon branching phenotype [Fig. 4(C,E)].
The effect on total axon length was particularly promi-
nent in Spry21/2 neurons [Fig. 4(F)]. Axon outgrowth
and elongation were further enhanced by basic FGF-2
and, particularly, following treatment with NGF [Fig.
4(D,F)]. Both factors induce axon branching already
in wt cultures [Klimaschewski et al., 2004, Fig. 4(E)].
Homozygous Spry2 knockout neurons did not exhibit
significantly increased axon outgrowth in response to
growth factor treatment.
The prominent elongative axon outgrowth effect in
Spry21/2 neurons was also visible in another type of
primary neuron culture. As demonstrated in Support-
ing Information Fig. 2, dissociated sympathetic SCG
Spry21/2 neurons extended significantly longer axons
with no change in number of axonal branch points.
Neuronal subpopulations in DRGs responded differ-
ently to reduced levels of Spry2. We observed that
large diameter neurons exhibited stronger effects than
small-diameter neurons with regard to axon elongation
by Spry21/2 neurons and branching by Spry22/2 neu-
rons as compared to wt (data not shown). Furthermore,
Spry2 deficient CGRP positive neurons displayed
enhanced total axon outgrowth with significantly ele-
vated maximal distance and numbers of axon branch
points. Conversely, the axon growth promoting effects
in IB4 binding Spry2 knockout neurons were weaker
[Fig. 4(G–I)], probably because IB4-binding neurons
are limited in their regenerative capacity in vitro
(Leclere et al., 2007). Nerve lesion in vivo promotes
axon growth primarily in myelinated DRG neurons,
but not in IB4-binding small nonmyelinated neurons
(Belyantseva and Lewin, 1999).
A possible correlation of the enhanced axon out-
growth in Spry2 deficient neurons with changes in
ERK activation was investigated by immunofluores-
cence applying pERK and ERK antibodies. As out-
lined in the Introduction, downregulation of Spry2
leads to the activation of Ras and ERK, whereas phos-
phorylation of AKT and p38 remains unaffected (Hau-
sott et al., 2009). In comparison to wt, Spry2 deficient
neurons exhibited increased basal pERK activity in
neuronal cell bodies 2 h and 24 h after plating [Fig.
4(J–L)]. Intensity measurements revealed elevated
pERK/ERK ratios in large Spry21/2 neurons and in
large as well as small Spry22/2 neurons [Fig. 4(M)].
Treatment with NGF or FGF-2 stimulated ERK phos-
phorylation in both genotypes with no changes in
pAKT/AKT levels (data not shown).
Peripheral Axon Regeneration in
Heterozygous Spry2 Knockout Mice
From the in vitro data, we hypothesized that moder-
ately reduced Spry2 levels may promote axon regen-
eration of sensory and motor neurons that express
Spry2 as well (Chambers and Mason, 2000). There-
fore, the sciatic nerve crush model was applied to
study peripheral nerve regeneration in Spry21/2 mice
in vivo. As stated above, homozygous Spry2 mice
could not be used as they did not recover from anes-
thesia required for nerve surgery.
Histological analysis of the sciatic nerve was per-
formed 28 days after injury distal to the crush site
[Fig. 5(A,B)]. Stereological methods were applied to
count myelinated fibers and to measure myelin thick-
ness. Following crush injury, the overall diameter of
the distal sciatic nerve [Fig. 5(C)] and the number of
myelinated axons [Fig. 5(D)] increased significantly,
while myelin thickness was not affected [Fig. 5(E)].
Axon diameters decreased in lesioned Spry21/2
knockout animals but this was statistically not signifi-
cant [Fig. 5(B,F)]. The number of Remak bundles
(Schwann cells enwrapping nonmyelinated axons)
was elevated with no change in the number of axons
per Remak bundle (5076 80 in wt vs. 6696 45 in
Spry21/2 mice, mean6SEM of n5 3 mice).
Before nerve injury and during nerve regeneration the
mice were tested behaviorally at regular intervals. The
baseline values in rotarod (sensomotor), von Frey’s
(mechanosensation), or Hangreaves’ tests (nociception)
were not changed in Spry21/2 mice as compared to wt
littermates [Figs. 1 and 6(A–D)]. However, significant
differences between heterozygous knockout and wt mice
were observed 3 weeks after lesion on the accelerating
rotarod which corresponds to the time period myelinated
axons require to reinnervate distal leg muscles. Follow-
ing sciatic nerve lesion, Spry21/2 mice improved their
performance by 2.96 0.5 % per day, whereas wt mice
improved only by 1.96 0.4% per day [Fig. 6(A)]. To
rule out different motor learning capabilities between
the two groups, nonlesioned mice of both genotypes
were subjected to 10 days of consecutive rotarod tests.
No significant differences in performance were apparent
[Fig. 6(B)]. Recovery of somatosensory function was
not affected following injury supporting our observation
that mainly myelinated axons regenerated faster in
Spry21/2 mice [Fig. 6(C,D)]. Furthermore, regeneration
of motor neurons was analyzed by endplate labeling in
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distal leg muscles. Alpha-bungarotoxine (BTX) staining
of the gastrocnemius muscle 4 weeks after surgery
revealed a higher density of motor endplates in Spry21/2
mice as compared to wt [Fig. 6(E–G)]. The results
suggest that Spry21/2 mice exhibit improved recovery
due to faster axon regeneration of mainly myelinated
axons as no differences were observed in nociceptive/
mechanosensory testing paradigms involving mainly
nonmyelinated axons.
Improved Long-Distance Regeneration is
Accompanied by Increased Axonal GAP-
43 in Spry21/2Mice
Regarding possible mechanisms of Spry2 inhibition, we
investigated mRNAs for GAP-43 and b-actin in the sci-
atic nerve by qRT-PCR. Local translation of these axo-
nal mRNAs regulates specific modes of axon
regeneration. Axonally targeted GAP-43 mRNA
increases axon length, whereas axonally targeted b-actin
stimulates axon branching of sensory neurons (Donnelly
et al., 2013). In fact, GAP-43 mRNA was significantly
upregulated 2 weeks after lesion in the distal sciatic
nerve of Spry21/2 mice as compared to wt [Fig. 7(A)].
This was accompanied by a statistically nonsignificant
trend toward increased axonal GAP-43 immunostaining
in Spry21/2 mice distal to the crush site [Fig. 7(B,C)]. It
has to be taken into account, however, that axonally
transported GAP-43 mRNA is translated mainly in the
tip of the axon, and the protein is transported antero-
gradely and present at higher levels in the growth cone
than in the axon shaft (Meiri et al., 1988, Tetzlaff et al.,
1989). No differences were observed with regard to b-
actin mRNA between Spry21/2 and wt nerves.
DISCUSSION
In this study, evidence is provided that reduction of
Spry2, a negative feedback inhibitor of receptor
Figure 5 Histomorphological analysis of toluidine blue stained myelinated axons in the sciatic
nerve (A,B) 4 weeks after nerve crush in Spry21/2 mice (A,B). The diameter of regenerated nerves
is larger (C) which is due to an increase in number of myelinated axons (D) with no change in mye-
lin thickness (E). A nonsignificant trend toward smaller axon diameters is observed in heterozygous
knockout nerves (B,F). Mean6 SEM of n> 6 mice per group. Bar5 20 lm
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tyrosine kinase signaling, stimulates axon outgrowth in
vitro and in vivo. For the first time, we demonstrate that
the two main modes of axon growth, elongation and
branching, depend on neuronal Spry2 levels in vivo.
Following sciatic nerve crush lesion, motor per-
formance improves faster in Spry21/2 mice than in
wt controls. This observation may be attributed to
higher numbers of regenerating myelinated axons as
well as muscle endplates and, at the molecular level,
to an induction of GAP-43, a downstream target of
ERK signaling (Murakami et al., 2011). Reduction of
Spry2 levels appears to affect predominantly large-
Figure 6 Functional recovery following sciatic nerve crush lesion in Spry21/2 mice and wt litter-
mates. Treadmill running (rotarod) reveals that Spry21/2 mice regenerate significantly faster than
wt mice (A). Motor learning was comparable during a 10-day training period in nonlesioned ani-
mals (B). Sensory tests analyzing the mechanical threshold in response to von Frey hairs (C) or the
pain threshold as paw withdrawal latency following a thermal stimulus (D) did not exhibit signifi-
cant differences (mean6SEM of n> 10 mice per group, arrow indicates time of injury). Alpha-
bungarotoxine (BTX) staining (E,F) in the gastrocnemius muscle demonstrates a significantly
higher density of motor endplates in Spry21/2 mice 4 weeks after injury (G). Mean6SEM of
n> 3 independent experiments. Bar5 45 lm
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sized motor and sensory (presumably proprioceptive)
neurons required for successful restoration of muscle
activity. Taken together, these findings are in accord-
ance with our previous work demonstrating that
siRNA mediated downregulation of Spry2 signifi-
cantly enhances axon elongation of peripheral and
central neurons in vitro (Hausott et al., 2009; Hausott
et al., 2012). They indicate that moderate reductions
of Spry2 positively affect axonal regeneration in the
peripheral and possibly also in the central nervous
system.
Spry2 inhibits the Ras/Raf/MEK/ERK cascade
downstream of growth factor activated receptor tyro-
sine kinases. This pathway is a key regulator of axon
outgrowth during development (Markus et al.,
2002a), although some aspects of early DRG and
motor neuron development were found to be ERK1/2
independent (Newbern et al., 2011). Activated recep-
tors signal via adaptor proteins, the GDP-GTP
exchange factor SOS and the small GTPase Ras. Ras,
in turn, stimulates the serine/threonine kinase Raf1
(MAPK kinase kinase), MEK1/2 (MAPK kinase),
and ERK1/2 (MAPK). Activated ERK1/2 is involved
in the translation of various axonal mRNAs and influ-
ences gene expression via phosphorylation of tran-
scription factors (Zhou and Snider, 2006). Target
genes of ERK include GAP-43 and Sprys themselves
which translocate to the plasma membrane and are
phosphorylated by Src kinase (Mason et al., 2006).
ERK is required for axotomy-induced growth cone
formation after lesion (Chierzi et al., 2005) and for
axon growth of preaxotomized DRG explants, which
Figure 7 Expression analysis of GAP-43 and b-actin mRNA in the distal sciatic nerve at 1, 3, and
14 days following a nerve crush lesion (A). Values are compared to the contralateral side and nor-
malized to nonlesioned nerves. Mean6SEM of n5 3 nerves per group. Transient upregulation of
b-actin mRNA is accompanied by prominent upregulation of GAP-43 mRNA 2 weeks after lesion
in Spry21/2 mice. Sciatic nerve sections obtained 2 weeks after crush injury reveal axonal (S100
negative) GAP-43 immunostaining (arrows in B and C). Fluorescence measurements indicate a
statistically nonsignificant trend toward increased GAP-43 levels in axons at 5 mm distal to the
crush site (mean6 SEM of n5 3 mice). Bars5 25 lm
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model in vivo conditions controlled by growth factors
(Wiklund et al., 2002). Local axon assembly depends
on ERK activity via modifications of axonal microtu-
bules, actin filaments and changes in local protein
translation in a growth factor dependent manner
(Atwal et al., 2000; Campbell and Holt, 2003; Goold
and Gordon-Weeks, 2005). Blockade of ERK results
in depolymerization of actin and in the collapse of
growth cones (Atwal et al., 2003). However, ERK
inhibitors apparently exert no effect on spontaneous
axon outgrowth of adult DRG explants, while neuro-
trophic factor induced growth is significantly
impaired (Sondell et al., 1999; Sjogreen et al., 2000).
In addition to ERK, the activation of phosphatidyl-
inositol 3-kinase (PI3K) plays a key role in axonal
elongation, branching, and gene expression underly-
ing axon maintenance (Zhou and Snider, 2006).
PI3K/AKT activity is not influenced by Spry2 down-
regulation in adult peripheral neurons (Hausott et al.,
2009), but increases axon caliber and branching fol-
lowing stimulation with growth factors in embryonic
DRG neurons (Markus et al., 2002b). Growth factors
like FGF-2 promote axon elongation by inducing
stronger activation of ERK than of AKT, whereas
NGF treatment primarily promotes axon branching
and results in both, ERK- and AKT-phosphorylation,
to a similar extent (Klimaschewski et al., 2004).
Spry2 deficient mice are expected to reflect the
phenotype of overexpressing neurotrophic factors
with regard to ERK signaling. For example, FGF-2
overexpressing mice (Jungnickel et al., 2006) and
Spry21/2 mice both reveal increased numbers of
regenerating myelinated axons after sciatic nerve
crush. However, no improvement in functional recov-
ery was observed in FGF-2 transgenic mice suggest-
ing differences in axon branching and/or myelination
between the two mouse models. While Spry2 defi-
cient mice did not exhibit significant changes in mye-
lination, FGF-2 overexpression resulted in reduced
myelin thickness most likely because of FGF-2 medi-
ated dedifferentiation and proliferation of Schwann
cells which lack Spry2.
The axon branching phenotype observed particu-
larly in homozygous Spry2 knockout cultures may be
involved in developmental changes of peripheral sen-
sory innervation. The increased number of free nerve
endings in the epidermis (indicating enlarged recep-
tive fields) combined with a higher number of non-
myelinated axons in the sciatic nerve and a greater
proportion of IB4 binding neurons in the DRG sug-
gest a lowered mechanosensitive threshold as
observed in von Frey testing. IB4 positive neurons
express receptors for glial-cell-line-derived neurotro-
phic factor and have been shown to be particularly
sensitive to Spry2 deficiency (Taketomi et al., 2005).
Moreover, they play a major role in mechanosensa-
tion (Molliver et al., 1997) and project to the epider-
mis (Zylka et al., 2005). In contrast, the
thermonociceptive threshold was elevated in Spry22/2
mice probably due to a diminished innervation of the
skin by CGRP positive fibers (which our antibody was
unable to detect). The CGRP-positive neuron popula-
tion corresponds almost exactly with the NGF respon-
sive, TrkA-expressing neuron population and is
mainly involved in thermonociception (Averill et al.,
1995). In support of this hypothesis, we observed a
trend toward reduced numbers of CGRP positive small
DRG neurons suggesting that in homozygous Spry2
knockout mice nociception may be perturbed.
In conclusion, this study reveals that Spry2 plays
an important role in limiting axon outgrowth during
development and nerve regeneration. ERK signaling
and downstream GAP-43 mRNA levels are enhanced
in Spry21/2 neurons. The induction of GAP-43 fol-
lowing nerve injury plays a key role in stimulation of
axon elongation without affecting axon branching
(Donnelly et al., 2013). Therefore, downregulation or
pharmacological inhibition of Spry2 may emerge as a
novel approach to promote long-distance regenera-
tion and faster reinnervation following injury in the
peripheral nervous system.
We are grateful to Rudolf Glueckert for help with the
mouse breeding, to Katrin Braun for help with neuron cul-
ture experiments, and to Andreas Frei and Aglaja Waibl for
help with image analysis.
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